We sought to demonstrate the feasibility of using single-shot spin-echo echo-planar imaging for imaging liver tumor necrosis in the in vivo VX2 rabbit model at 1.5 T. Materials and Methods: VX2 liver tumors were grown in 4 rabbits. Diffusion-weighted images (DWIs) were acquired during breathhold using twice refocused SE-EPI (b ϭ 0, 700, 1400 seconds/mm 2 ). Anatomic images for tumor size measurements were acquired using T2W TSE. Rabbits were euthanized for subsequent necropsy. Viable and necrotic tumor tissue ADC measurements were performed with reference to hematoxylin and eosin pathology. Results: A total of 8 tumors were grown with diameters ranging from 1.2 to 5.3 cm. Viable and necrotic tumor compartments were clearly differentiated. Apparent diffusion coefficient in necrotic tumor cores, 1.26 Ϯ 0.11 ϫ 10 Ϫ3 mm 2 /s, were significantly greater than those in surrounding viable tumor tissues, 0.74 Ϯ 0.06 ϫ 10 Ϫ3 mm 2 /s (mean Ϯ SD, P Ͻ 0.05).
M agnetic resonance imaging (MRI) techniques using motion probing gradients to exploit the phenomenon of intravoxel incoherent motion (IVIM) can produce diffusionweighted images and apparent diffusion coefficient (ADC) parametric maps. 1 The most common clinical application for diffusion-weighted imaging (DWI) has been for the early detection of stroke. 2 However, DWI is increasingly being used to evaluate tumor tissues in both animal models and patients. DWI has been used to detect tumors, 3 to differentiate lesion types, 4 to differentiate malignant tissues from benign tissues surrounding tumors, 5 and to detect diffusion changes secondary to the alteration of microscopic capillary perfusion and tumor cell structures after therapy. 6 For tumor staging or the assessment of tumor therapies, DWI offers an attractive alternative to anatomic size measurements and/or histopathology particularly because (1) changes in size may not correlate with therapeutic efficacy; (2) size changes may occur with significant delays relative to functional changes in tumor physiology; and (3) the invasive nature of histopathology complicates longitudinal studies.
Early speculation that DWI could differentiate viable from necrotic tumor tissues 7 was later validated by multiple systemic studies in melanoma, 8 squamous cell carcinoma, 9 and breast tumor 10 murine models as well as a limited number of patient studies. 11 Decreased cellularity and compromised cell membrane integrity in necrotic tissue 12 allows locally increased diffusion of water molecules. Later studies validated the use of DWI for differentiating viable from necrotic tumor tissues in the VX2 rabbit model of hepatocellular carcinoma (HCC) at 4.7 T. 13 HCC therapies commonly involve the catheter-directed administration of embolic materials, 14 chemotherapy drugs 15 or, more recently, Y90 radioactive microspheres. 16 Therefore, it is critical that assessment of therapeutic efficacy be performed in a large animal model permitting catheterization of the hepatic artery. The VX2 rabbit provides a particularly useful model for liver cancer because these animals are large enough to permit catheterization 13 and the VX2 liver tumor blood supply is almost entirely from the hepatic artery analogous to human HCC. 17 The VX2 rabbit is currently the superior animal model for the development of catheter-directed therapies. However, previously validated procedures for DWI of VX2 rabbit liver tumors at 4.7 T involved euthanizing each animal before imaging. Such a requirement would preclude the use of DWI for longitudinal assessment of tumor therapies. To use DWI for longitudinal studies of therapeutic efficacy in VX2 rabbits, these DWI techniques must be validated in vivo. Furthermore, validation of these techniques at 1.5 T would facilitate use of this animal model for the development novel DWI techniques at this more clinically applicable field strength. The purpose of this preliminary study was to demonstrate the feasibility of using single-shot diffusion-weighted single-shot spin-echo echo-planar imaging (SE-EPI) for imaging liver tumor necrosis in the in vivo VX2 rabbit model at 1.5 T.
MATERIALS AND METHODS

Animal Model
All experiments received Animal Care and Use Committee approval. The rabbit VX2 tumor model is an accepted liver tumor model in large animals. 13 The VX2 tumor biochemical phenotype is characteristic of advanced stage tumors, with high glycolysis and elevated levels of mitochondrial bound hexokinase. 18 Experiments were performed using 4 New Zealand white rabbits weighing approximately 5 kg. VX2 cells were initially grown in the hindlimb of a separate donor rabbit. After 30 days, harvested hindlimb tumor was minced and placed in sterile Hanks solution. For surgical VX2 liver implantation, each of the 4 remaining rabbits were anesthesized with intramuscular (IM) ketamine 44 mg/kg and xylazine 3-5 mg/kg and administered inhaled isofluorane 2-3% as needed during the procedure. After sterile preparation of the subxiphoid area, a mini-laparotomy was performed, 6 -8 cm, exposing the liver. Minced pieces of harvested VX2 tumor were implanted with injections into the left liver lobe using an 18-gauge angiocatheter outer cannula. Abdomen was closed using 3-layer technique. Liver tumors were incubated for approximately 30 days before imaging.
Rabbits were intubated with a 3-French endotracheal tube and administered isofluorane anesthesia. Breath-holding was performed using a small animal ventilator (Harvard Apparatus, Holliston, MA) with continuous end tidal pCO 2 monitoring. To avoid stimulation of respiratory drive resulting from increasing pCO 2 levels while breath-holding, rabbits were hyperventilated before each breath-hold. Hyperventilation was achieved by increasing the ventilator rate from a baseline of 65 breaths/min to 75 breaths/min for a time interval (ϳ45 seconds) sufficient to decrease pCO 2 from a baseline of ϳ40 mm Hg to 28 -30 mm Hg.
MRI
MRI was performed using a 1.5 T Magnetom Sonata clinical MR scanner (Siemens Medical Solutions, Erlangen, Germany). Rabbits were imaged in the supine position using a flexible surface coil conforming to the shape of the abdomen. Rabbits remained intubated for isofluorane administration during the MRI procedures. Anatomic and diffusion weighted images were acquired at identical axial slice positions.
Anatomic images of the liver were acquired using a T2-weighted turbo spin-echo (T2W TSE) sequence with the following imaging parameters: TR/TE ϭ 3000/82 milliseconds, 4-mm slice thickness, 130-Hz/pixel BW, 200 ϫ 100 mm 2 field of view, 256 ϫ 126 matrix (0.8 ϫ 0.8 ϫ 4.0-mm 3 voxel size), turbo factor ϭ 7, averages ϭ 4. Diffusion-weighted images of the liver were acquired during breath-hold using an SE-EPI sequence ( Fig. 1 ) with the following imaging parameters: TR/TE ϭ 3000/100 milliseconds, 4-mm slice thickness, 750-Hz/pixel BW, nonselective fat saturation, twice refocused spin-echo diffusion weighting to reduce eddy-current induced distortion 19 was applied along the readout axis with 3 b-values of 0, 700, and 1400 seconds/mm 
Histology
After removal from the scanner bore, each rabbit was euthanized with commercial intravenous Beuthanasia solution containing pentobarbital (100 mg/kg). Rabbit livers were harvested for subsequent necropsy. Livers were fixed in 10% buffered formaldehyde solution and sliced at 3-to 4-mm intervals in the axial plane to correspond to the plane of the MR images. Tumor nodules were embedded in paraffin for histologic examination. These nodules were sliced in 4-m thick sections and stained using hematoxylin and eosin (H&E) to confirm tumor necrosis. An Olympus BX40 microscope was used for H&E slide inspection (ϫ100 optical magnification) with an image of each slide stored in the TIFF file format for later viewing on a PC (Dell Precision 850 Workstation).
Image Analysis
A Siemens Argus image processing workstation was used to measure axial tumor diameter in each T2W TSE anatomic image. At those slice positions corresponding to the maximal axial diameter in each tumor, region-of-interest (ROI) measurements were performed. Separate ROI for mean ADC measurements were drawn in viable peripheral rim regions and central necrotic regions of each tumor. Gross tumor morphology was altered by the fixation process and therefore direct correlation between necropsy specimens and corresponding in vivo MR images was not possible. Nec-FIGURE 1. Single-shot DW SE-EPI pulse sequence diagram with nonselective fat saturation (FS) and twice refocused spin-echo diffusion weighting preparation scheme followed by echo-planar readout (RF ϭ radiofrequency excitation and receive, SS ϭ slice selection gradient axis, PE ϭ phaseencode gradient axis, RO ϭ readout gradient axis). 
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RESULTS
A total of 8 liver tumors were grown in 4 VX2 rabbits. Although respiratory motion artifacts were commonly observed in the T2W TSE images, particularly at slice positions near the dome of the liver, these artifacts did not preclude measurements of tumor diameter or the accurate positioning of subsequent DWI scans at tumor locations. No motion artifacts were observed in the diffusion weighted images acquired during breath-holding. Representative T2W TSE anatomic images and diffusion weighted images with corresponding ADC maps for 2 rabbits are shown in Figures 2 and 3 .
Tumor diameter and the measured ADC values for viable and necrotic tissues within each tumor are shown in Table 1 . 
DISCUSSION
These studies demonstrated the feasibility of using a 1.5 T clinical MRI scanner for in vivo single-shot DW SE-EPI imaging of liver tumor necrosis in the VX2 rabbit model. No respiratory motion artifacts were observed during breath-hold DWI studies. The measured ADC values in 
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Investigative Radiology /s respectively. However, each of these studies used relatively small sample sizes and somewhat divergent imaging protocols (different pulse sequences, b-values, tumor cell lines). Additional studies are necessary to determine the source of these variations.
Although histologic specimens correlated well with corresponding ADC maps, each showing a viable tumor periphery with a necrotic core, accurate registration between H&E slides and diffusion weighted images remained a limitation of this study. In future studies, a more systematic comparison of pathology slides to ADC maps may be possible. With multiple axial ADC maps sampled to cover the entire 3D volume of each tumor, a specific ADC value could be chosen as a viable tissue cut-off value to derive a tumor viability fraction. Whole tumor DWI-based tumor viability fraction could be compared with the viability fraction derived at pathology. 8 For the larger VX2 tumors in this study, the relative signal intensity for T2-weighted TSE images was well correlated to viable peripheral and necrotic central regions of the tumors as depicted by the ADC maps. This correlation is most likely the result of cystic reorganization of the necrotic tissue microstructure at later stages of tumor growth. 20 Future studies may be useful to establish the time course relationship between T2-weighted signal intensity and VX2 tumor tissue viability, particularly with respect to therapy response. However, it was reported that at intermediate stages of tumor growth, when the necrotic core is just beginning to form, T2-weighted images show relatively homogenous signal intensities across the tumor. 9 Also, multiple clinical HCC imaging studies have reported that T2-weighted images do not accurately represent the pattern of necrosis confirmed pathologically after resection. 21, 22 Additional HCC studies have demonstrated that different tumor necrosis phenomena may have different appearances in T2-weighted images (hypointensity may reflect coagulation necrosis while hyperintensity may reflect liquefaction or intratumoral hemorrhage accompanying tumor necrosis). [23] [24] [25] [26] Further studies are necessary to establish the potentially complimentary information provided by T2 and diffusion weighted images in the VX2 rabbit model.
Although the single-shot techniques used in this study avoided artifacts resulting from bulk tissue motion during application of the DW gradients, the spatial resolution provided by these techniques was limited due to T2 relaxation effects and image degradation resulting from off-resonance artifacts. 27 The ability to accurately define the margins between necrotic tissue and at risk viable tissue would be of significant clinical utility but the spatial resolution and signalto-noise ratio currently provided by conventional single-shot techniques remains inadequate for these purposes. Future improvements in spatial resolution and image quality may be possible with multishot DWI pulse sequences, including interleaved-EPI with phase-correcting navigator echoes, 28 line-scan DWI, 29 and TSE DWI using either radial k-space acquisition 30 or the more recently developed PROPELLOR acquisition. 31 Sonography is an alternative noninvasive imaging method that has been used recently to evaluate tumor necrosis. Several studies have been performed in an attempt to associate histology with sonographic features such as echogenicity, echotexture and heterogeneity for estimation of necrosis in melanoma metastases. 32, 33 However, these studies were limited to a superficial skin tumor model. Although Rouffiac et al 33 have quantified the correlation between echogenicity and the degree of melanoma necrosis, the parametric intratumoral pattern necessary to visually differentiate necrotic from viable tissues has not been reported. Two HCC sonography studies 34, 35 have been performed in an effort to correlate the echogenic characteristics of focal liver lesions with different histologic features. However, discrepant results were reported when attempting to correlate echogenic features with tumor histology.
Contrast-enhanced MRI is another alternative method to differentiate viable and necrotic tumor tissues. However, the conventional extracellular contrast agent diffuses rapidly into the interstitial space, thereby enhancing necrotic tissues as well as viable tissues. 11 This complication may be resolved by performing dynamic contrast-enhanced studies and/or using macromolecular contrast agents. 36 Recent radiation therapy studies in VX2 rabbits demonstrated significant changes in macromolecular contrast agent gadomer-17 enhancement characteristics 37 and dynamic contrast enhanced studies in Ewing sarcomas demonstrated a strong correlation between enhancement characteristics and tumor necrotic fraction. 38 Additional studies are exploring the feasibility of using novel necrosis avid contrast agents to differentiate viable from necrotic tissues. 39 Future studies are needed to compare the accuracy of these DW, dynamic contrast-enhanced, and macromolecular agent enhanced techniques for differentiating viable and necrotic tumor tissues. However, many patients will not tolerate the breath-holding periods required for dynamic contrast enhanced studies in the liver and most macromolecular agents remain in early preclinical stages.
DWI techniques commonly used for early detection of stroke 2 are increasingly being investigated for oncologic imaging applications. DWI has demonstrated significant potential in a wide range of clinical imaging applications including whole-body assessment of bone marrow disease, 3, 40 differentiation of lesion types, 4 and differentiation of malignant tissues from benign tissues surrounding tumors.
5 DWI may soon be used for routine clinical evaluation of the liver.
In conclusion, in vivo DWI of liver tumor necrosis in the VX2 rabbit model is feasible using a 1.5 T clinical MRI scanner. Necrotic tumor tissues demonstrated significantly increased ADC compared with viable tissues, as verified by pathologic analysis. DWI may offer significant utility in the longitudinal assessment of novel liver tumor treatments in both the rabbit model and patients.
